An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis. Kim G, Tauhid S, Dupuy SL, Tummala S, Khalid F, Healy BC, Bakshi R J Neurol. 2016 Jan 11. Epub 2016 Jan 11. PMID: 26754005. Abstract CommentRecommendBookmarkWatch